Evidence map›Paper›PMID 27870875›Full record

ArticlePloS one2016

A Novel Organ Culture Model to Quantify Collagen Remodeling in Tree Shrew Sclera.

Sarah Baldivia, Alexander Levy, Shylaja Hegde, Stijn J A Aper, Maarten Merkx, Rafael Grytz

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A Novel Tree Shrew (Tupaia belangeri) Model of Glaucoma.Investigative ophthalmology & visual science · 2018
    Article
  8. Experimental myopia increases and scleral crosslinking using genipin inhibits cyclic softening in the tree shrew sclera.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Sarah BaldiviaDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Alexander LevyDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Shylaja HegdeDepartment of Vision Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Stijn J A AperDepartment of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, The Netherlands.
Maarten MerkxDepartment of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, The Netherlands.
Rafael GrytzDepartment of Ophthalmology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.ORCID http://orcid.org/0000-0001-9539-4070
University of Alabama at Birmingham · USEindhoven University of Technology · NL

Funding

Visual Phenotyping CoreP30EY003039 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LAWRENCE C SINCICH · 1985 to 2026
$16.9M
Scleral Remodeling in MyopiaR01EY026588 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Rafael Grytz · 2016 to 2026
$4.1M
The influence of ocular remodeling on glaucomaR01EY027759 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GRYTZ, RAFAEL, SAMUELS, BRIAN CHRISTOPHER · 2017 to 2021
$2.3M
NEI NIH HHS P30 EY003039NEI NIH HHS R01 EY026588NEI NIH HHS R01 EY027759
6 · The paper itself

Abstract

Increasing evidence suggests that unknown collagen remodeling mechanisms in the sclera underlie myopia development. We are proposing a novel organ culture system in combination with two-photon fluorescence imaging to quantify collagen remodeling at the tissue- and lamella-level. Tree shrew scleral shells were cultured up to 7 days in serum-free media and cellular viability was investigated under: (i) minimal tissue manipulations; (ii) removal of intraocular tissues; gluing the eye to a washer using (iii) 50 μL and (iv) 200 μL of cyanoacrylate adhesive; (v) supplementing media with Ham's F-12 Nutrient Mixture; and (vi) culturing eyes subjected to 15 mmHg intraocular pressure in our new bioreactor. Two scleral shells of normal juvenile tree shrews were fluorescently labeled using a collagen specific protein and cultured in our bioreactor. Using two-photon microscopy, grid patterns were photobleached into and across multiple scleral lamellae. These patterns were imaged daily for 3 days, and tissue-/lamella-level strains were calculated from the deformed patterns. No significant reduction in cell viability was observed under conditions (i) and (v). Compared to condition (i), cell viability was significantly reduced starting at day 0 (condition (ii)) and day 3 (conditions (iii, iv, vi)). Tissue-level strain and intralamellar shear angel increased significantly during the culture period. Some scleral lamellae elongated while others shortened. Findings suggest that tree shrew sclera can be cultured in serum-free media for 7 days with no significant reduction in cell viability. Scleral fibroblasts are sensitive to tissue manipulations and tissue gluing. However, Ham's F-12 Nutrient Mixture has a protective effect on cell viability and can offset the cytotoxic effect of cyanoacrylate adhesive. This is the first study to quantify collagen micro-deformations over a prolonged period in organ culture providing a new methodology to study scleral remodeling in myopia.

Indexed as

AnimalsBioreactorsCell SurvivalCollagenCulture Media, Serum-FreeMyopiaOrgan Culture TechniquesRefraction, OcularScleraTupaiidaeCollagenCulture Media, Serum-Free

Identifiers

PMID27870875
PMCPMC5117658
OpenAlexW2556209024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.